Purpose: The goal of this study was to validate the ultrasonography (US) and cytopathological features that are used in the diagnosis of the follicular variant of papillary thyroid carcinoma (FVPTC) and to characterize the role of BRAF V600E mutation analysis in the diagnosis of FVPTC. 
Purpose: The goal of this study was to validate the ultrasonography (US) and cytopathological features that are used in the diagnosis of the follicular variant of papillary thyroid carcinoma (FVPTC) and to characterize the role of BRAF V600E mutation analysis in the diagnosis of FVPTC.
Methods: From May 2012 to February 2014, 40 thyroid nodules from 40 patients (mean age, 56.2 years; range, 26 to 81 years) diagnosed with FVPTC were included in this study. The US features of the nodules were analyzed and the nodules were classified as probably benign or suspicious for malignancy. Twenty-three thyroid nodules (57.5%) underwent BRAF V600E mutation analysis. Clinical information and histopathologic results were obtained by reviewing the medical records of the patients. Results: Thirty nodules (75.0%) were classified as suspicious for malignancy, while 10 (25.0%) were classified as probably benign. Seven of the eight nodules (87.5%) with atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) cytology showed suspicious US features, while one of the two nodules (50.0%) with follicular neoplasm cytology presented suspicious US features. Five of the 23 nodules (21.7%) that underwent BRAF V600E mutation analysis had positive results, all of which were diagnosed as suspicious for malignancy or malignant based on cytology. None of the nodules with benign, AUS/FLUS, or follicular neoplasm cytology were positive for the BRAF V600E mutation.
Conclusion: US features allow nodules to be classified as suspicious for malignancy, and the presence of suspicious US features in nodules with ambiguous cytology may aid in the diagnosis of FVPTC. BRAF V600E mutation analysis is of limited value in the diagnosis of FVPTC.
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Introduction
Papillary thyroid carcinoma (PTC) is the most common malignancy of the thyroid gland [1, 2] , and numerous variants of PTC have been reported with distinct histopathological features [3] .
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Conventional or classical PTC is the most frequent type, while the follicular variant of papillary thyroid carcinoma (FVPTC) is the second most common variant; these variants comprise approximately 55%-66% and 11.8%-31.6% of well differentiated thyroid carcinomas, respectively [1] [2] [3] [4] [5] . Cytologically, FVPTC contains cells that show the nuclear features of PTC, such as ground glass nuclei, nuclear grooves, and overlapping nuclei with or without nuclear inclusions [2, 6] , with a predominantly follicular growth pattern [4, 7] . Although FVPTC has been reported to have a lower rate of lymph node metastasis and extrathyroidal extension-than classical PTC [3, 7, 8] , but a higher rate of lung and bone metastasis [2, 9] , it is generally accepted that the clinical behavior of FVPTC resembles that of PTC, with similar patient outcomes [3, 4, 8, 10, 11] . Since the prognosis and the longterm survival outcomes of patients with FVPTC are similar to those of patients with classical PTC, the same treatment strategies are currently applied to this variant form of thyroid carcinoma [3] [4] [5] 11] . Many studies have evaluated the clinicopathological features and long-term outcomes of FVPTC alone or in comparison with classical PTC [3, 4, [6] [7] [8] 10, 11] , whereas few studies have evaluated the ultrasonography (US) features of FVPTC [2, 9] The US features of each thyroid nodule were described according to the following categories: internal components, echogenicity, margin, calcifications, and shape [14] . Based on their internal components, nodules were classified as solid, predominantly solid (solid contents comprising more than 50% of the nodule), or predominantly cystic (solid contents comprising less than 50% of the nodule). Based on echogenicity, nodules were classified as hyperechoic or isoechoic (nodules showing hyperechogenicity or isoechogenicity when compared to the surrounding thyroid parenchyma), hypoechoic (nodules showing hypoechogenicity compared to the surrounding thyroid parenchyma), and markedly hypoechogenic (nodules showing hypoechogenicity compared to the adjacent strap muscle). The margins were classified as circumscribed or non-circumscribed (i.e., microlobulated or irregular margins). Based on the presence of calcifications, nodules were classified as having no calcifications, microcalcifications or mixed calcifications, or macrocalcifications including eggshell calcifications. The shape was classified as parallel or non-parallel (greater in the anteroposterior dimension than the transverse dimension, or 'taller than wide'). Of these features, the US features considered indicative of malignancy were marked hypoechogenicity, non-circumscribed margins, microcalcifications or mixed calcifications, and a nonparallel shape, based on previously established criteria [14] . The final assessment of the thyroid nodules was 'probably benign' when none of the suspicious US features described above were present, and as 'suspicious for malignancy' when one or more of the suspicious US features were present.
US-FNA was performed at least twice from each thyroid nodule using a 23-gauge needle attached to a 2-mL disposable syringe without an aspirator. Local anesthesia was not routinely applied. The aspirated material was expelled onto glass slides and immediately placed in 95% ethanol for Papanicolaou staining. The remaining material in the syringe was rinsed in saline for cell block processing. The cytopathologists were not present during the procedures, and additional staining was performed on a case-by-case basis at the request of the cytopathologists. One of the seven cytopathologists specializing in thyroid pathology interpreted the cytology slides. During the period of the study, cytology reports involving US-FNA of the thyroid classified nodules according to the six categories in the Bethesda System for Reporting Cytopathology: non-diagnostic, benign, atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), follicular neoplasm or suspicious for follicular neoplasm, suspicious for malignancy, and malignancy [15] .
During the US-FNA procedures, aspiration was performed once more for BRAF V600E mutation analysis if requested by the referring physicians. Of the 40 thyroid nodules included in this study, 23 (57.5%) underwent BRAF V600E mutation analysis. The aspirated material was rinsed in 1 mL of normal saline, which was sent for BRAF V600E mutation analysis. Real-time polymerase chain reaction was used for detecting the BRAF V600E mutation during the study period at our institution [16] . Two of the 40 thyroid nodules underwent US-guided core needle biopsy due to repeated inconclusive cytology results. This procedure was performed using the freehand technique with a spring-activated 18-gauge Tru-Cut-type needle (Acecut, TSK Laboratory, Tochigi, Japan). At least three biopsy cores were obtained, and the specimen was fixed in formalin solution and sent to the pathology department.
Results
The size of the 40 thyroid nodules confirmed as FVPTC ranged from 4 to 53 mm (mean, 12.6±12.2 mm). Four nodules (10.0%) were palpable, while the remaining 36 (90.0%) were incidentally detected. Table 1 summarizes the clinical and pathological features of the 40 patients included in this study. Twenty-five nodules (62.5%) were encapsulated, while 15 (37.5%) were pathologically determined to be infiltrative. Six patients (15.0%) had multifocal lesions, and the remaining 34 (85.0%) had single lesions. Central or lateral cervical lymph node metastases were found in seven patients (17.5%) and two patients (5.0%), respectively. Table 2 summarizes the US features of the 40 thyroid nodules diagnosed as FVPTC in this study. The common US features observed among the 40 thyroid nodules were as follows: solid composition (92.5%), hypoechogenicity (62.5%), microlobulated margins (55.0%), no calcifications (37.5%), and a parallel shape (67.5%). Thirty nodules (75.0%) were classified as suspicious for malignancy, while 10 (25.0%) were classified as probably benign. Table 3 shows the correlations of cytological characteristics with US features and the BRAF V600E mutation analysis results of the 40 FVPTC nodules. Of the 40 thyroid nodules, the preoperative cytology results were as follows: benign findings were observed in one nodule (2.5%) (Fig. 1) , AUS/FLUS findings in eight nodules (20.0%) (Fig. 2) , follicular neoplasm or suspicious for follicular neoplasm findings in two nodules (5.0%), a finding of suspicious for malignancy in 16 nodules (40.0%), and malignancy in 13 nodules (32.5%). Two nodules underwent US-guided core needle biopsy; both showed non-confirmative results, suggesting the possibility of follicular proliferative lesions. Ten nodules were assessed as probably benign, the cytology results were suspicious for malignancy or malignant in seven (70.0%), follicular neoplasm or suspicious for follicular neoplasm findings were observed in one nodule (10.0%), AUS/FLUS findings in one nodule (10.0%), and benign findings in one nodule (10.0%). Seven nodules (87.5%) with AUS/ 
Discussion
FVPTC has been reported to have a relatively benign appearance compared to the typical US features seen in the classical variant of PTC [2, 9] . The common US features of FVPTC observed in our study were a solid composition, hypoechogenicity, microlobulated margins, no calcifications, and a parallel shape, corresponding to the results of previous studies [2, 9] . Each of these individual features is either a typically benign feature or is consistent with but not strongly suggestive of malignancy. Interestingly, although the most common US features of FVPTC in our study and in previous reports were typically benign, 75.0% (30 of 40 nodules) had more than one suspicious US feature. This observation indicates the importance of US features in predicting malignancy in thyroid nodules, which can be used as a guideline for patient management according to US-FNA cytology results. US-FNA is considered the gold standard in the diagnosis of thyroid nodules, showing a high sensitivity of 83%-98% [8, 12, 14] and enabling benign nodules suitable for conservative follow-up to be differentiated from malignant nodules that require surgical intervention. However, US-FNA has limitations in the accurate diagnosis of FVPTC. The presence of a follicular arrangement of tumor cells is the cytological hallmark of FVPTC, and the presence of high cellularity, follicles and syncytial clusters, nuclear features of grooves, and enlarged nuclei with fine chromatin has been reported helpful in diagnosing FVPTC [3, 17] . However, the characteristic cytological features described above are not always apparent, since these features may be focal or localized and not included during sampling procedures [3, 16] . Moreover, it is difficult to distinguish between various follicular lesions of the thyroid, including benign adenomatous nodules, and follicular carcinomas based on cytological features alone [18] . The sensitivity of US-FNA cytology for the diagnosis of FVPTC has been reported to be lower than for 23 nodules that underwent BRAF V600E mutation analysis were included. Considering the difficulties involved in the definitive diagnosis of FVPTC based on cytological features alone, several reports have applied molecular studies including BRAF V600E mutation analysis to the diagnosis of FVPTC [1, 12] in mutated lesions that already have suspicious or malignant cytology results [16] . Our results correspond to those of previous studies; five of the 23 nodules that underwent A B Fig. 1 . An incidentally detected thyroid mass in a 32-year-old woman. A, B. Ultrasonography (A, transverse; B, longitudinal) shows a 4.3-cm well-defined, predominantly solid mass with isoechoic features, a parallel shape, and no calcifications in the left thyroid. The final assessment of this thyroid mass was probably benign. C. Ultrasonographyguided fine needle aspiration cytology shows (H&E, ×400) sheets of follicular cells without significant atypia, and the results of BRAF V600E mutation analysis were negative. Diagnostic lobectomy was performed due to the large size of the mass, and follicular variant of papillary thyroid carcinoma was confirmed on pathology. D. Microscopic images of the tumor (H&E, ×400) shows neoplastic follicles containing eosinophilic colloid, lined by cells with irregular nuclei that show nuclear grooves (arrow) and suspicious pseudoinclusion (arrowhead).
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Ultrasonography 35(1), January 2016 e-ultrasonography.org known to be associated with a lower rate of the BRAF V600E mutation than classical PTC [20] . Moreover, several reports have shown a high frequency of RAS mutations in FVPTC [21] , which may be useful in the preoperative diagnosis of FVPTC, although further research is required to reveal which molecular marker or markers are specific for FVPTC. This study has some limitations. First, this was a retrospective study of lesions diagnosed as FVPTC after surgery, meaning that BRAF V600E mutation analysis were positive for the mutation, of which two had suspicious and three had malignant cytology results. None of the nodules with benign, AUS/FLUS, or follicular neoplasm cytology results showed positive results in BRAF V600E mutation analysis. Therefore, we suggest that BRAF V600E mutation analysis is of limited value for providing additional information in the differential diagnosis of FVPTC. Debate continues regarding the role of BRAF V600E mutations in the diagnosis of FVPTC, as FVPTC is A B Fig. 2 . An incidentally detected thyroid mass in a 62-year-old woman. A, B. Ultrasonography (A, transverse; B, longitudinal) shows a 2.3-cm hypoechoic solid mass with microlobulated margins, macrocalcifications, and a parallel shape in the left thyroid. The final assessment of this thyroid mass was suspicious for malignancy. C. Ultrasonography-guided fine needle aspiration (US-FNA) cytology (H&E, ×100) demonstrates a low cellular aspirate composed of microfollicles and scattered isolated cells, and the results BRAF V600E mutation analysis were negative. The patient underwent surgery due to the repeated presence of atypia of undetermined significance/follicular lesion of undetermined significance results on follow-up US-FNA, and this mass was confirmed as the follicular variant of papillary thyroid carcinoma on surgery. D. Microscopic images of the tumor (H&E, ×400) shows neoplastic follicles of variable size and shape, with lines near the cells containing eosinophilic colloid, lined by cells with irregular nuclei that show prominent nucleoli, nuclear grooves (arrows) and suspicious pseudoinclusion (arrowhead). 
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